GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bone Biologics Corp (NAS:BBLGW) » Definitions » Net Interest Income (for Banks)

Bone Biologics (Bone Biologics) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Bone Biologics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Bone Biologics (Bone Biologics) Business Description

Traded in Other Exchanges
Address
2 Burlington Woods Drive, Suite 100, Burlington, MA, USA, 01803
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.